MEDGADGET EDITORS eSight, a company based in Toronto, Canada, is releasing the latest version of its vision-improving electronic glasses for people with poor eyesight and even legal blindness. The eSight 4 sports two 1280×960 screens that display images captured and processed from the forward facing camera on the glasses. It’s indicated for people with all...
by Marilynn Marchione For the first time, a blood test has been shown to help detect many types of cancer in a study of thousands of people with no history or symptoms of the disease. The test is still experimental. Even its fans say it needs to be improved and that Tuesday’s results are not...
CHOP researchers evaluate feasibility, safety and benefit potential of project: EVO Platform CHILDREN‘S HOSPITAL OF PHILADELPHIA Philadelphia, January 3, 2019–Researchers at Children‘s Hospital of Philadelphia (CHOP) evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder (ASD) and co–occurring attention/deficit-hyperactivity disorder (ADHD). The results of the study, published in the Journal of Autism and Developmental Disorders, confirmed the acceptability, feasibility, and...
